Phathom Pharmaceuticals Inc (PHAT)
SG&A Expense Growth
2.44%
Quarterly · Period ending:
PHAT SG&A Expense Growth
Latest reported2.44%period ending
Latest reported2.44%period ending
PHAT Quarterly SG&A Growth (QoQ) (0.00% → 2.44%)
Latest values, visible window
High-resolution chart · PNG
PHAT sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 2.4421% | |
| 11.6599% | |
| -6.1814% | |
| -39.5661% | |
| -9.6968% | |
| 23.2007% | |
| 0.7674% | |
| 0.2992% | |
| 22.3545% | |
| 9.1514% | |
| 144.0859% | |
| 22.9075% | |
| 1.8228% | |
| -39.0789% | |
| 30.8305% | |
| -12.1064% | |
| 31.9614% | |
| 3.2381% | |
| 17.8958% | |
| 20.4562% | |
| 5.5214% | |
| 20.5749% | |
| 52.762% | |
| 36.7687% | |
| 14.4568% | |
| 50.8866% | |
| 64.8649% | |
| 34.7955% | |
| 68.7578% | |
| 82.3799% | |
| 66.7939% | |
| 3.5573% | |
| 0% | |
| 0% |